एपीए उद्धरण

Créquit, P., Yavchitz, A., Trinquart, L., Ravaud, P., & Cadranel, J. (2018). Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second‐line treatment for non–small‐cell lung cancer wild‐type or unknown status for EGFR. Cochrane Database Syst Rev.

शिकागो स्टाइल उद्धरण

Créquit, Perrine, Amelie Yavchitz, Ludovic Trinquart, Philippe Ravaud, और Jacques Cadranel. "Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Versus Single Agent Chemotherapy As Second‐line Treatment for Non–small‐cell Lung Cancer Wild‐type or Unknown Status for EGFR." Cochrane Database Syst Rev 2018.

एमएलए उद्धरण

Créquit, Perrine, et al. "Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Versus Single Agent Chemotherapy As Second‐line Treatment for Non–small‐cell Lung Cancer Wild‐type or Unknown Status for EGFR." Cochrane Database Syst Rev 2018.